miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study

por Gagez, Anne-Laure, Duroux-Richard, Isabelle, Leprêtre, Stéphane, Orsini-Piocelle, Frédérique, Letestu, Rémi, De Guibert, Sophie, Tuaillon, Edouard, Leblond, Véronique, Khalifa, Olfa, Gouilleux-Gruart, Valérie, Banos, Anne, Tournilhac, Olivier, Dupuis, Jehan, Jorgensen, Christian, Cartron, Guillaume, Apparailly, Florence
Publicado 2017

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

por Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, Stamatoullas, Aspasia, Banos, Anne, Laribi, Kamel, Jueliger, Simone, Bevan, Luke, Chermat, Fatiha, Sapena, Rosa, Nibourel, Olivier, Chaffaut, Cendrine, Chevret, Sylvie, Preudhomme, Claude, Adès, Lionel, Fenaux, Pierre
Publicado 2019

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia

por Contejean, Adrien, Resche-Rigon, Matthieu, Tamburini, Jérôme, Alcantara, Marion, Jardin, Fabrice, Lengliné, Etienne, Adès, Lionel, Bouscary, Didier, Marçais, Ambroise, Lebon, Delphine, Chabrot, Cécile, Terriou, Louis, Barraco, Fiorenza, Banos, Anne, Bussot, Lucile, Cahn, Jean-Yves, Hirsch, Pierre, Maillard, Natacha, Simon, Laurence, Fornecker, Luc-Matthieu, Socié, Gerard, de Latour, Regis Peffault, de Fontbrune, Flore Sicre
Publicado 2019

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

por Aubrais, Raphaelle, Bouabdallah, Krimo, Chartier, Loic, Herbaux, Charles, Banos, Anne, Brice, Pauline, Sibon, David, Schiano, Jean Marc, Cluzeau, Thomas, Laribi, Kamel, Le Calloch, Ronan, Bellal, Mathieu, Delapierre, Baptiste, Daguindau, Nicolas, Amorim, Sandy, Agbetiafa, Kossi, Chauchet, Adrien, Besson, Caroline, Durot, Eric, Bonnet, Christophe, Fouillet, Ludovic, Bijou, Fontanet, Tournilhac, Olivier, Gaulard, Philippe, Parrens, Marie-Cécile, Damaj, Gandhi
Publicado 2022

P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL

por Kim, Rathana, Bergugnat, Hugo, Pasquier, Florence, Raffoux, Emmanuel, Larcher, Lise, Passet, Marie, Pastoret, Cedric, Nathalie, Grardel, Asnafi, Vahid, Delabesse, Eric, Caye-Eude, Aurélie, Meyer, Claus, Masrschalek, Rolf, Thiebaut-Bertrand, Anne, Balsat, Marie, Escoffre, Martine, Blum, Sabine, Baumann, Michael, Banos, Anne, Straetmans, Nicole, Pilar Gallego Hernanz, Maria, Chalandon, Yves, Graux, Carlos, Leguay, Thibaut, Hunault, Mathilde, Huguet, Françoise, Lhéritier, Véronique, Soulier, Jean, Boissel, Nicolas, Clappier, Emmanuelle
Publicado 2023

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML

por de Botton, Stéphane, Cluzeau, Thomas, Vigil, Carlos, Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A., Liesveld, Jane L., Fenaux, Pierre, Braun, Thorsten, Banos, Anne, Jurcic, Joseph G., Sekeres, Mikkael A., Savona, Michael R., Roboz, Gail J., Bixby, Dale, Madigan, Kate, Volkert, Angela, Stephens, Kristin, Kang-Fortner, Qing, Baker, Kristen, Paul, Sofia, McKeown, Michael, Carulli, John, Eaton, Matthew, Hodgson, Graeme, Fiore, Christopher, Kelly, Michael J., Roth, David A., Stein, Eytan M.
Publicado 2022

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

por Michallet, Anne-Sophie, Letestu, Rémi, Le Garff-Tavernier, Magali, Campos, Lydia, Ticchioni, Michel, Dilhuydy, Marie-Sarah, Morisset, Stephane, Rouille, Valérie, Mahé, Béatrice, Laribi, Kamel, Villemagne, Bruno, Ferrant, Emmanuelle, Tournilhac, Olivier, Delmer, Alain, Molina, Lysiane, Leblond, Véronique, Tomowiak, Cécile, de Guibert, Sophie, Orsini-Piocelle, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan-Graczyk, Margot, Vilque, Jean-Pierre, Schleinitz, Thérèse Aurran, Cymbalista, Florence, Leprêtre, Stéphane, Lévy, Vincent, Nguyen-Khac, Florence, Feugier, Pierre
Publicado 2023

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

por Gressin, Rémy, Daguindau, Nicolas, Tempescul, Adrian, Moreau, Anne, Carras, Sylvain, Tchernonog, Emmanuelle, Schmitt, Anna, Houot, Roch, Dartigeas, Caroline, Pignon, Jean Michel, Corm, Selim, Banos, Anne, Mounier, Christiane, Dupuis, Jehan, Macro, Margaret, Fleury, Joel, Jardin, Fabrice, Sarkozy, Clementine, Damaj, Ghandi, Feugier, Pierre, Fornecker, Luc Matthieu, Chabrot, Cecile, Dorvaux, Veronique, Bouadallah, Krimo, Amorin, Sandy, Garidi, Reda, Voillat, Laurent, Joly, Bertrand, Celigny, Philippe Solal, Morineau, Nadine, Moles, Marie Pierre, Zerazhi, Hacene, Fontan, Jean, Arkam, Yazid, Alexis, Magda, Delwail, Vincent, Vilque, Jean Pierre, Ysebaert, Loic, Le Gouill, Steven, Callanan, Mary B.
Publicado 2019